Product Program year 2025 Source: CMS Open Payments

Mynx Control Venous

Device Cardiology/Vascular Diseases

Open in the dashboard

General payments

$166,284

2,099 payments

Research payments

$0

0 payments

Through program year 2025, $166,284 in general payments and $0 in research payments were reported against Mynx Control Venous (Cardiology/Vascular Diseases).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $166,284 2,099

Breakdown

Who paid General payments · program year 2025
  1. Cordis US Corp. $166,284 2,099 payments
Top recipients General payments · program year 2025
  1. Mohamed Elshazly Clinical Cardiac Electrophysiology · Lake Mary, FL $15,235 9% · 13 payments
  2. Erin Murphy Vascular Surgery · Charlotte, NC $13,385 8% · 7 payments
  3. Joseph Bumgarner Clinical Cardiac Electrophysiology · Raleigh, NC $12,750 8% · 2 payments
  4. Kevin Makati Cardiovascular Disease · Lutz, FL $10,884 7% · 2 payments
  5. Sanjaya Gupta Clinical Cardiac Electrophysiology · Kansas City, MO $5,818 3% · 5 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Clinical Cardiac Electrophysiology Internal Medicine $55,503 33% · 300 practitioners
  2. Interventional Cardiology Internal Medicine $27,240 16% · 218 practitioners
  3. Vascular Surgery Surgery $24,799 15% · 50 practitioners
  4. Cardiovascular Disease Internal Medicine $23,692 14% · 200 practitioners
  5. Vascular & Interventional Radiology Radiology $8,203 5% · 41 practitioners

The top 5 of 48 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $41,385 25% · 82 recipients
  2. North Carolina $32,034 19% · 53 recipients
  3. California $11,408 7% · 107 recipients
  4. New York $10,766 6% · 113 recipients
  5. Texas $9,783 6% · 71 recipients

The top 5 of 47 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

2,099 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record